Clinical Trials on COPD, Chronic Obstructive Pulmonary Disease

Total 48206 results

Centre Hospitalier des Pays de Morlaix
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Completed

Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients

Chronic Obstructive Pulmonary Disease | COPD

France
AstraZeneca

Completed

Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany
AstraZeneca

Completed

A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Nuvaira, Inc.

Completed

Evaluation of the IPS System for TLD Therapy in Patients With COPD (IPS-II)

Chronic Obstructive Pulmonary Disease (COPD)

France, Austria
Centre Hospitalier du Centre du Valais
Swiss National Science Foundation; University of Lausanne Hospitals; Promotion... and other collaborators

Completed

Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Switzerland
Mayo Clinic

Completed

Mindfulness Based Stress Reduction in COPD

Chronic Obstructive Pulmonary Disease | COPD

United States
Almirall, S.A.

Completed

Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Netherlands
Edmond Pharma

Unknown

The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) (RESTORE)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium, Bulgaria, Czech Republic, Denmark, France, Italy, Poland, Romania, Slovakia, United Kingdom
Norwegian University of Science and Technology

Completed

Effects of Aerobe Interval Training and Moderate Continuous Training in Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease | COPD

Norway
Laval University

Completed

Electrostimulation, Skeletal Muscle Function, and Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD) (ESTIM)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Mayo Clinic
Pfizer; Boehringer Ingelheim

Completed

Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation

Chronic Obstructive Pulmonary Disease | COPD

United States
Takeda

Completed

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | COPD

United States
AstraZeneca

Completed

A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Fondazione Salvatore Maugeri

Unknown

Tracheostomized COPD Patients and Non Invasive Mechanical Ventilation

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Novartis

Completed

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, France
Laval University
GlaxoSmithKline

Completed

Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation

Chronic Obstructive Pulmonary Disease (COPD)

Canada
The Hong Kong Polytechnic University

Completed

Effects of a 4-week Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) Program on Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
AstraZeneca
Parexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

Chronic Obstructive Pulmonary Disease - COPD

United Kingdom
Glenmark Specialty S.A.

Completed

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

United States
Tilburg University
Fonds NutsOhra; Revant Schoondonck Center for Pulmonary Rehabilitation Breda; Revant Innovation foundation

Completed

Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD

Chronic Obstructive Pulmonary Disease COPD

Netherlands
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD

United States, Australia, New Zealand
AstraZeneca

Recruiting

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations (MIRANDA)

Chronic Obstructive Pulmonary Disease (COPD)

China, United States, Denmark, Italy, Canada, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, India, Japan, Vietnam, Malaysia, Thailand, Korea, Republic of, Mexico, Brazil, Greece, Poland, France, Peru, Chil... and more
AstraZeneca
Parexel

Completed

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients (TRIBUTE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pearl Therapeutics, Inc.

Completed

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

COPD

United States
Guangzhou Institute of Respiratory Disease

Completed

Quality Control for Chronic Obstructive Pulmonary Disease

COPD

China
Bayside Health
Newcastle University; Austin Health

Completed

Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease

COPD

Australia
Fisher and Paykel Healthcare
Medical Research Institute of New Zealand; Alana Healthcare

Terminated

Nasal High Flow Therapy 30 Day Readmission Study (N3ADS)

Chronic Obstructive Pulmonary Disease | COPD

United States, New Zealand
Chiesi Farmaceutici S.p.A.

Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD (GlycoNEXT)

Chronic Obstructive Pulmonary Disease (COPD)

Czechia, Germany, Hungary, Romania
Cardiff University
GlaxoSmithKline; Cardiff Metropolitan University

Completed

Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

Phase IV O2 Consumption Study in COPD Patients.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
Assiut University

Unknown

VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients

COPD

Egypt
Radboud University Medical Center

Unknown

Exacerbation Self-management in COPD: The ACCESS Study (ACCESS)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
Brigham and Women's Hospital
AstraZeneca

Terminated

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo (AZCO)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pearl Therapeutics, Inc.

Completed

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Aarhus
Aarhus University Hospital

Completed

Magnesium is Associated With QoL in COPD: A Cross-sectional Study

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Universidad de Granada

Completed

Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease

COPD

Spain
Medical University of Warsaw

Unknown

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

COPD

Poland
University Hospital Southampton NHS Foundation...
GlaxoSmithKline

Completed

Microbiology & Immunology of the Chronically-inflamed Airway (MICA)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Novartis Pharmaceuticals

Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico
Novartis Pharmaceuticals

Completed

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Chronic Obstructive Pulmonary Disease (COPD)

United States, Poland, Romania, Canada, Philippines, Spain, Ukraine, Vietnam
Eisai Co., Ltd.

Completed

Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

COPD

Japan
Fundación Pública Andaluza Progreso y Salud

Completed

Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily (ROFLU2011)

Chronic Obstructive Pulmonary Disease (COPD)

Spain
COPD Foundation
National Jewish Health

Completed

COPD Research Registry

Chronic Obstructive Pulmonary Disease (COPD)

United States
Lallemand Pharma AG
Sprim Advanced Life Sciences

Completed

Advanced Immunological Approach in COPD Exacerbation (AIACE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Nicolaas J Smit PhD

Completed

A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease

COPD

United States
Novartis Pharmaceuticals

Completed

12-week Open-label Evaluation of Efficacy and Safety of Indacaterol (MOVE-ON)

Chronic Obstructive Pulmonary Disease (COPD)

Israel
AstraZeneca

Completed

CorRELation Between PatIent PErception and Findings on Clinical Examination (RELIEF)

Chronic Obstructive Pulmonary Disease (COPD)

Romania

Clinical Trials on COPD, Chronic Obstructive Pulmonary Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations